InflaRx (NASDAQ:IFRX) Price Target Raised to $10.00 at Guggenheim
InflaRx (NASDAQ:IFRX – Free Report) had its target price hoisted by Guggenheim from $7.00 to $10.00 in a report published on Wednesday morning, MarketBeat Ratings reports. The brokerage currently has a buy rating on the stock. Separately, HC Wainwright reiterated a “buy” rating and issued a $8.00 price target on shares of InflaRx in a […]
